SIRT1 Gene Polymorphism With Premature Myocardial Infarction in Young Egyptian Patients
NCT ID: NCT05160844
Last Updated: 2024-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
280 participants
OBSERVATIONAL
2021-09-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endothelial NO Synthase Polymorphic Gene in Coronary Artery Dilation Disease
NCT06220682
The Impact of Genetic Polymorphism on the Echocardiographic Parameters and Cardiac Fibrosis Markers in Response to Empagliflozin Treatment Among Patients With Heart Failure
NCT06503601
Early Repolarization Syndrome: Define the Risk, Stratify the Coverage and Understand the Causes - Clinical and Genetic Study
NCT02847039
Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy
NCT06896266
Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy
NCT02852018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diseased
young Egyptian patients with premature myocardial infarction
No interventions assigned to this group
Control
healthy young Egyptians
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with malignancies, major trauma or surgery in the previous six months, and acute or chronic infectious disease
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amera Morad Foad
clinical professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amera Morad Foad hamdy, lecturer
Role: PRINCIPAL_INVESTIGATOR
Sohag faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag uniersity hosoital
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-21-11-33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.